CoChat

Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder

Johnston-Wilson, N L, Sims, C D, Hofmann, J-P, Anderson, L, Shore, A D, Torrey, E F, Yolken, R H, the Stanley Neuropathology Consortium · 2000 · Molecular Psychiatry

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Severe psychiatric disorders such as schizophrenia, bipolar disorder and major depressive disorder are brain diseases of unknown origin. No biological marker has been documented at the pathological, cellular, or molecular level, suggesting that a number of complex but subtle changes underlie these illnesses. We have used proteomic technology to survey postmortem tissue to identify changes linked to the various diseases. Proteomics uses two-dimensional gel electrophoresis and mass spectrometric sequencing of proteins to allow the comparison of subsets of expressed proteins among a large number of samples. This form of analysis was combined with a multivariate statistical model to study changes in protein levels in 89 frontal cortices obtained postmortem from individuals with schizophrenia, bipolar disorder, major depressive disorder, and non-psychiatric controls. We identified eight protein species that display disease-specific alterations in level in the frontal cortex. Six show decreases compared with the non-psychiatric controls for one or more diseases. Four of these are forms of glial fibrillary acidic protein (GFAP), one is dihydropyrimidinase-related protein 2, and the sixth is ubiquinone cytochrome c reductase core protein 1. Two spots, carbonic anhydrase 1 and fructose biphosphate aldolase C, show increase in one or more diseases compared to controls. Proteomic analysis may identify novel pathogenic mechanisms of human neuropsychiatric diseases.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.mp.4000696

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 45 references

Cited by

See all 531

Metadata

Authors
Johnston-Wilson, N. L., Sims, C. D., Hofmann, J.-P., Anderson, L., Shore, A. D., Torrey, E. F., Yolken, R. H., & the Stanley Neuropathology Consortium
Affiliations
Johns Hopkins University (US)
Corresponding author
Johnston-Wilson, N L
Venue
Molecular Psychiatry
Published
2000-03-01
Volume
5
Issue
2
Pages
142-149
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2328048826
Cited by
531
References
45
Citations by year
2026: 5 · 2025: 8 · 2024: 17 · 2023: 14 · 2022: 12 · 2021: 27 · 2020: 19 · 2019: 14 · 2018: 22 · 2017: 16 · 2016: 29 · 2015: 27 · 2014: 29 · 2013: 22 · 2012: 27
FWCI
9.79
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Molecular Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords
schizophrenia, bipolar disorder, major depressive disorder, frontal cortex, brain proteins, postmortem brain, proteomics, glial fibrillary acidic protein, carbonic anhydrase I, biomarkers
MeSH terms
Collapsin Response Mediator Protein 1, Amino Acid Sequence, Autopsy, Bipolar Disorder, Carbonic Anhydrases, Depressive Disorder, Frontal Lobe, Fructose-Bisphosphate Aldolase, Glial Fibrillary Acidic Protein, Humans, Image Processing, Computer-Assisted, Molecular Sequence Data, Nerve Tissue Proteins, Peptide Fragments, Reference Values, Schizophrenia, Electron Transport Complex III, Electrophoresis, Gel, Two-Dimensional

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. https://app.cochat.ai/papers/10.1038/sj.mp.4000696
The paper
Johnston-Wilson, N. L., Sims, C. D., Hofmann, J.-P., Anderson, L., Shore, A. D., Torrey, E. F., Yolken, R. H., & the Stanley Neuropathology Consortium. (2000). Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. Molecular Psychiatry. https://doi.org/10.1038/sj.mp.4000696

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.